Report cover image

World Market for Infectious Disease Immunoassays

Published Oct 05, 2017
Length 180 Pages
SKU # KLI15498315

Description

World Market for Infectious Disease Immunoassays

This report contains important business data for the infectious disease immunoassay, market, a high-growth area of immunoassy IVD testing. The report contains: Global Lab-based Infectious Disease Immunoassay Market Sizing for the following infection types:
  • Hepatitis 
  • HIV
  • STD
  • TORCH
  • Respiratory
  • HAIs
  • Other Infectious Disease  
Kalorama Information's report, The World Market for Infectious Disease Immunoassays, provides important business planning data for companies in the immunoassay market, investing in the field, or considering expansion. The following are among the data provided in the report:

  •  Global Lab-based Infectious Disease Immunoassay Sales 2016 [Hepatitis, HIV, STD, TORCH, Respiratory, HAIs, Other Infectious Disease (in millions$))
  •  Global Lab-based Infectious Disease Immunoassay Market Share % 2016
  •  Lab-Based Immunoassay Market by Geographic Region 2021
  •  POC Infectious Disease Immunoassay Market
  •  Lab-Based Immunoassay Infectious Disease Market by Country (US, Germany, France, UK, Italy, Spain, China, Brazil, Saudi Arabia, Turkey, Canada)
  •  POC Infectious Disease Immunoassay Market by Country(US, Germany, France, UK, Italy, Spain, China, Brazil, Saudi Arabia, Turkey, Canada)
  •  Trends and Information
  •  Corporate Profiles
 
Some infectious disease immunoassays are being replaced with molecular assays. For example, most chlamydia and gonorrhea testing in developed countries is performed with molecular diagnostic assays rather than with immunoassays. A major driving factor in this conversion to molecular testing for chlamydia and gonorrhea was the increased sensitivity of these molecular tests compared to traditional immunoassays, and especially compared to traditional rapid tests such as lateral flow-based assays. However, many improvements have been made with immunoassays to improve the technical performance of these assays, including better sensitivity. Innovations in immunoassay technology and platforms have been discussed in Chapter 4, and many companies developing these new, innovative platforms are profiled in this report.

A key area of immunoassay testing is in detecting infectious diseases.  The infectious disease immunoassay market is large because of the many different infectious agents affecting the population.  Common infectious disease immunoassays performed in central laboratories are typically categorized into groups such as hepatitis, retroviral testing, sexually transmitted diseases, TORCH, and other infectious diseases. Infectious disease immunoassays are used in point-of-care setting or when rapid testing is needed. Immunoassays are also used to screen blood and blood products in order to prevent transfusion-transmitted infections.  

Companies involved in the infectious disease immunoassay market include:
  • Accubiotech Co, Ltd.
  •  Alere Inc
  •  Arkray, Inc
  •  Arlington Scientific, Inc.
  •  Atlas Link Biotech Co., Ltd
  •  Beckman Coulter, Inc
  •  Becton Dickinson (Bd)
  •  Biokit S.A.
  •  Biomerieux Sa
  • Bio-Rad Laboratories Inc
  • Bioscan Screening Systems, Inc.
  • Chembio Diagnostic Systems, Inc.
  • Diasource Immunoassays Sa
  • Elitechgroup, Inc.
  • Erba Diagnostics, Inc.
  • Grifols International S.A.
  • Hema Diagnostic Systems, Llc
  • Labsystems Diagnostics Oy
  • Luminex Corporation
  • Medix Biochemica
  • Medmira, Inc
  • Meridian Bioscience, Inc
  • Nano-Ditech Corporation
  • Novatec Immunodiagnostica Gmbh
  • Oncimmune Holdings Plc.
  • One Lambda
  • Operon
  • Orasure Technologies, Inc.
  • Quidel Corporation
  • Response Biomedical Corp
  • Savyon Diagnostics Ltd.
  • Sekisui Diagnostics
  • Siemens Healthineers
  • Standard Diagnostics, Inc.
  • Teco Diagnostics
  • Thermo Fisher Scientific, Inc
  • Trinity Biotech Plc
  • Wako Diagnostics

Table of Contents

180 Pages
    • Overview
    • Scope and Methodology
    • Future Prospects in the Infectious Disease Immunoassay Market
    • History and Future of Immunoassays
    • Point of View
    • Overview - Instrument Platforms
    • Specimen Types
    • Rapid and Point-of-Care Testing
    • Immunoassay Market - Market Drivers and Changes
    • Emerging International Markets
    • Outlook for Immunoassays
    • Size and Growth of Market
    • Lab-based Infectious Disease Immunoassay Market by Disease
    • Point of Care/Rapid Test Immunoassays
    • Market by Country - Lab-Based
    • Market by Country-Point of Care
    • Abbott Corporate Summary
    • Company Overview
    • Product
    • Company Financials
    • AccuBioTech Co, Ltd.
    • Alere Inc
    • ARKRAY, Inc
    • Arlington Scientific, Inc.
    • Atlas Link Biotech Co., Ltd
    • Beckman Coulter, Inc
    • Becton Dickinson (BD)
    • Biokit S.A.
    • bioMerieux SA
    • Bio-Rad Laboratories Inc.
    • Bioscan Screening Systems, Inc.
    • Chembio Diagnostic Systems, Inc.
    • DiaSource ImmunoAssays SA
    • ELITechGroup, Inc.
    • ERBA Diagnostics, Inc.
    • Grifols International S.A.
    • Hema Diagnostic Systems, LLC
    • Labsystems Diagnostics Oy
    • Luminex Corporation
    • Medix Biochemica
    • MedMira, Inc
    • Meridian BioScience, Inc
    • Nano-Ditech Corporation
    • Novatec Immunodiagnostica GmbH
    • Oncimmune Holdings Plc.
    • One Lambda
    • Operon
    • OraSure Technologies, Inc.
    • Quidel Corporation
    • Response Biomedical Corp
    • Savyon Diagnostics Ltd.
    • Sekisui Diagnostics
    • Siemens Healthineers
    • Standard Diagnostics, Inc.
    • Teco Diagnostics
    • Thermo Fisher Scientific, Inc
    • Trinity Biotech PLC
    • Wako Diagnostics
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.